Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT03179514

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03179514
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03179514. Randomized; no masking; primary purpose treatment. Start 2017-07 (anticipated); primary completion 2019-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.
Condition
Unstable Angina
Intervention (Drug)
Anti-Platelet Drugs
Intervention (Drug)
Lipid Regulating Drugs
Intervention (Drug)
Coronary Vasodilator
Intervention (Drug)
Gualou Xiebai Banxia Decoction & Danshen Decoction
Lead sponsor
Jun Li (class: other)
Collaborator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct03179514
Content hash
4fe3bf863abb64b1e0364b7102380a8ec11d648b47e390fcf5252293f9fa9fd3